Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Liwei Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9485-6138; OpenAlex author ID A5049437598. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. A nanomedicine enables synergistic chemo/photodynamic therapy for pancreatic cancer treatment. Co-author DOI 10.1039/d2bm00437b↗
  2. TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway. Co-author DOI 10.3389/fonc.2021.628353↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingfang Fan · 2 shared papers, 2021–2022 · strength 0.27
  2. Jin Geng · 1 shared paper, 2022 · strength 0.15
  3. Xianxing Wang · 1 shared paper, 2021 · strength 0.12
  4. Junfeng Zhang · 1 shared paper, 2021 · strength 0.12
  5. Jianyou Gu · 1 shared paper, 2021 · strength 0.12
  6. Tian Tao · 1 shared paper, 2021 · strength 0.12
  7. Huaizhi Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.